Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › SCCE modified transgenic mammals and their use as models of human disease

SCCE modified transgenic mammals and their use as models of human disease

US Patent 7019194 · Granted Mar 28, 2006

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the production of hyperpolarized 129Xe2011
Methods and devices configured for dissolving hyperpolarised solid material with2008
Fibrinolytic enzymes2004
DNA encoding human .kappa. casein and process for obtaining the protein2001
Transgenic non-human mammal expressing the DNA sequence encoding kappa casein ma2001
Borrelia burdorferi Osp A and B proteins and immunogenic peptides2000
Packaging unit for continuously producing sealed packages, containing pourable f2000
Packaging unit for continuously producing sealed packages, containing pourable f2000
Transgenic non-human mammals producing EC-SOD protein in their milk2000
Recombinant stratum corneum chymotryptic enzyme (SCCE)1999
Recombinant stratum corneum chymotryptic enzyme (SCCE)1999
Phosphorylated recombinant human .beta.-casein expressed in a bacterial system1999